Floatz logo

Calcium folinate pentahydrate

Small Cell Lung Carcinoma

Seagen, a wholly owned subsidiary of PfizerSmall moleculePhase 1/2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
44/ 100
Competitive Position
81/ 100

Competitive context

20 Active assets in the Small Cell Lung Carcinoma cohort.

Asset / SponsorPhaseRating
IMMUNOGLOBULIN G2, ANTI-(HUMAN CTLA-4 (ANTIGEN)) (HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 HEAVY CHAIN) DISULPHIDE WITH HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 LIGHT CHAIN, DIMER
Alliance Foundation Trials, LLC.
Phase 3B
Regorafenib
Neonc Technologies, Inc.
Phase 2B
Eloxatin
Chongqing University Cancer Hospital
Phase 2B
lbh581
Southern Europe New Drug Organization
Phase 2B
Amuvatinib
Astex Pharmaceuticals, Inc.
Phase 2B

View all 39 →

Same molecule, other indications

Calcium folinate pentahydrate is also rated in:

Advanced KRAS Positive Metastatic Colorectal CancerDormant
BBB
Indicative ·
78 / 100
View asset →
Recurrent Pancreatic CarcinomaDormant
BBB
Indicative ·
78 / 100
View asset →
Stage IV Colon CancerDormant
BBB
Indicative ·
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →